Precision nicotine metabolism-informed care for smoking cessation in Crohn’s disease: A pilot study

INTRODUCTION: Smoking is a strong risk factor for disease severity in Crohn’s disease (CD) and cessation improves outcomes. The nicotine metabolite ratio (NMR) predicts cessation success with pharmacotherapy: varenicline doubles cessation over nicotine replacement therapy (NRT) for “normal”, but not...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Scoville, Elizabeth A., Tindle, Hilary A., Wells, Quinn S., Peyton, Shannon C., Gurwara, Shelly, Pointer, Stephanie O., Horst, Sara N., Schwartz, David A., Adams, Dawn W., Freiberg, Matthew S., Gatskie, Vanessa, King, Stephen, Abney, Lesa R., Beaulieu, Dawn B.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7098646/
https://ncbi.nlm.nih.gov/pubmed/32214373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0230656
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars